Active Solicitation
AI Summary
The Defense Health Agency is seeking proposals for the development of an analgesic product for battlefield pain management. This competitive Request for Prototype Proposal aims to create a product for moderate to severe pain, with potential FDA approval for use during Tactical Combat Casualty Care. Multiple awards may be made, with proposals expected in late 2026.
The Defense Health Agency Contracting Activity (DHACA), Research & Development Contracting Division 2, intends to issue a Request for Prototype Proposal (RPP) on behalf of the Operational Medical Systems, Warfighter Protection and Acute Care Project Management Office for Battlefield Pain Management – Analgesic.
The intent is to issue a competitive RPP for the development of an analgesic product with a moderate to severe pain indication through the Food and Drug Administration approval for use on the battlefield, at the point of injury, during Tactical Combat Casualty Care, and/or during Prolonged Casualty Care. The proposal will be open to any analgesic product, including combination products, to ensure that competition and innovation will be maximized.
Subject to the availability of funds and evolving Government requirements, multiple awards may be made for the development of up to two products, with an Emergency Use Authorization as a potential strategy for early delivery to the Warfighter.
DHACA intends to publish the RPP in Quarter 3 – Quarter 4, Fiscal Year 2026 with up to two awards expected to be delivered in Quarter 1 – Quarter 2, Fiscal Year 2027. No telephone calls will be accepted.
BATTLEFIELD PAIN MANAGEMENT – ANALGESIC is a federal acquisition solicitation. Review the full description, attachments, and submission requirements on SamSearch before the response deadline.
SamSearch Platform
AI-powered intelligence for the right opportunities, the right leads, and the right time.